Related Experiment Videos
Properties of liposomes containing 212Pb
International Journal of Nuclear Medicine and Biology
|January 1, 1983
Summary
Researchers developed lead-212 (212Pb) liposomes for potential therapeutic applications. These liposomes showed altered distribution in vivo and suppressed immune responses, indicating their potential for targeted delivery and immunomodulation.
Area of Science:
- Biochemistry
- Nanotechnology
- Immunology
Background:
- Liposomes are versatile nanocarriers for drug delivery.
- Radioisotopes can be incorporated into liposomes for targeted therapies.
- Understanding liposome behavior in biological systems is crucial for their application.
Purpose of the Study:
- To prepare and characterize lipid bilayer vesicles containing the radioisotope lead-212 (212Pb).
- To investigate the stability, in vivo distribution, and immunomodulatory effects of 212Pb-loaded liposomes.
Main Methods:
- Reverse phase evaporation technique for liposome preparation.
- Electron microscopy and microfiltration for liposome size determination.
- In vivo distribution studies and assessment of humoral immune response.
Main Results:
- Liposomes successfully encapsulated 212Pb and other markers.
- Serum exposure caused isotope leakage, preventable by complexation or precipitation.
- 212Pb liposomes exhibited altered in vivo distribution, with clearance by the reticuloendothelial system.
- Surface-modified liposomes were immunogenic and suppressed humoral responses.
Conclusions:
- 212Pb liposomes can be prepared with controlled properties.
- Strategies exist to enhance liposome stability in biological fluids.
- These liposomes demonstrate potential for targeted delivery and immune modulation in vivo.